R&D Systems™ Recombinant Human Oncostatin M (HEK-293-expressed)

Description

Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility. Applications: Bioactivity

The Recombinant Human Oncostatin M (HEK-293-expressed) is derived from HEK293. The Recombinant Human Oncostatin M (HEK-293-expressed) has been validated for the following applications: Bioactivity.

Specifications

• Accession Number: P13725
• For Use With (Application): Bioactivity
• Gene ID (Entrez): 5008
• Molecular Weight (g/mol): Observed M.W.: 27-35kDa, reducing conditions, Theoretical M.W.: 22kDa
• Quantity: 10 μg
• Source: Human embryonic kidney cell,HEK293-derived human Oncostatin M/OSM protein Ala26-Arg221
• Storage Requirements: Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70° C as supplied. 1 month, 2 to 8° C under sterile conditions after reconstitution. 3 months, -20 to -70° C under sterile conditions after reconstitution.
• Endotoxin Concentration: <0.10 EU per 1μg of the protein by the LAL method.
• Gene Alias: MGC20461, oncostatin M, oncostatin-M
• Common Name: Oncostatin M/OSM
• Gene Symbol: OSM
• Biological Activity: Measured in a cell proliferation assay using TF-1 human erythroleukemic cells. Kitamura, T. et al. (1989) J. Cell Physiol. 140:323. The ED50 for this effect is typically 0.05-0.3ng/mL.
• Conjugate: Unconjugated
• Species: Human
• Recombinant: Recombinant
• Expression System: Human embryonic kidney cell, HEK293-derived Ala26-Arg221
• Purity or Quality Grade: >95%, by SDS-PAGE with Silver Staining